Patexia Research

Case number 1:11-cv-00607

Lawsuits

Abbott Laboratories et al v. Watson Laboratories Inc. - Florida > Summary

Court Case Number 1:11-cv-00607

Filing Date Jul 8, 2011

Court Delaware District Court

Status Unknown

Plaintiff

2

Abbott Laboratories

Abbott Respiratory Llc

Defendant

2

Watson Laboratories

Watson Pharma Private ltd

Plaintiff Attorneys

4

Abbott Laboratories
Attorney Name: Mary B. Graham
Morris Nichols Arsht & Tunnell

ABBOTT RESPIRATORY LLC
Attorney Name: Mary B. Graham
Morris Nichols Arsht & Tunnell

Abbott Laboratories
Attorney Name: Erich William Struble
Morris Nichols Arsht & Tunnell

ABBOTT RESPIRATORY LLC
Attorney Name: Erich William Struble
Morris Nichols Arsht & Tunnell

Defendant Attorneys

8

Watson Laboratories
Attorney Name: Karen E. Keller
Shaw Keller LLP

Watson Pharma Private ltd
Attorney Name: Karen E. Keller
Shaw Keller LLP

Watson Laboratories
Attorney Name: Karen E. Keller
Shaw Keller LLP

Watson Laboratories
Attorney Name: Pilar G. Kraman
Young Conaway Stargatt & Taylor

Watson Laboratories
Attorney Name: Adam W. Poff
Young Conaway Stargatt & Taylor

Watson Laboratories
Attorney Name: John W. Shaw
Shaw Keller LLP

Watson Pharma Private ltd
Attorney Name: John W. Shaw
Shaw Keller LLP

Watson Laboratories
Attorney Name: John W. Shaw
Shaw Keller LLP

Counter Defendant

4

Abbott Laboratories
Attorney Name: Mary B. Graham
Morris Nichols Arsht & Tunnell

ABBOTT RESPIRATORY LLC
Attorney Name: Mary B. Graham
Morris Nichols Arsht & Tunnell

Abbott Laboratories
Attorney Name: Erich William Struble
Morris Nichols Arsht & Tunnell

ABBOTT RESPIRATORY LLC
Attorney Name: Erich William Struble
Morris Nichols Arsht & Tunnell

Counter Claimant

2

Watson Laboratories
Attorney Name: Karen E. Keller
Shaw Keller LLP

Watson Laboratories
Attorney Name: John W. Shaw
Shaw Keller LLP

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
07011848	Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor	Mar 14, 2006
06818229	Intermediate release nicotinic acid compositions for treating hyperlipidemia	Nov 16, 2004
06746691	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics	Jun 8, 2004
06676967	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia	Jan 13, 2004
06469035	Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid	Oct 22, 2002
06406715	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles	Jun 18, 2002
06129930	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night	Oct 10, 2000
06080428	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor	Jun 27, 2000